Pitas, Baby Girl .
HRN: 24-06-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2023
MUPIROCIN 2%, 15G (TUBE)
11/23/2023
11/30/2023
TOPICAL
1ml
TID
Skin Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes